Click Here for 5% Off Your First Aladdin Purchase!

AC 186 - 98%, high purity , CAS No.1421854-16-1, Agonist of Estrogen receptor-α;Agonist of Estrogen receptor-β

  • Moligand™
  • ≥98%
Item Number
A288374
Grouped product items
SKUSizeAvailabilityPrice Qty
A288374-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$76.90
A288374-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$119.90
A288374-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$199.90
A288374-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$324.90
A288374-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$469.90

Potent and selective ERβ agonist; neuroprotective

Basic Description

Synonyms4-[4,4-Difluoro-1-(2-fluorophenyl)cyclohexyl]phenol
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsPotent and selective ERβagonist (EC50values are 6 and 5000 nM for ERβand ERαrespectively). Exhibits gender selective neuroprotective effects in a male rat model of Parkinson's disease. Decreases Aβlevels in combination with ACP-105 in a rat model of Alzhe
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeAGONIST
Mechanism of actionAgonist of Estrogen receptor-α;Agonist of Estrogen receptor-β
Product Description

product description:

AC-186 is a non-steroidal estrogen receptor β (ERβ) agonist (EC50 = 6 nM in a functional assay).1 It is selective for ERβ over ERα (EC50 = 5,000 nM). AC-186 (10 mg/kg) reduces dopaminergic neuronal loss in the substantia nigra, improves novel object recognition, and improves motor performance in male, but not female, rats in a model of Parkinson’s disease induced by 6-OHDA (Item No. 25330). It reduces tactile allodynia in male, but not female or female ovariectomized, rats in a model of spinal nerve ligation-induced neuropathic pain.2 AC-186 (10 and 30 mg/kg) also reduces tactile allodynia in male rats in a model of neuropathic pain induced by paclitaxel.

Associated Targets

ESR1 Tclin Estrogen receptor 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ESR2 Tclin Estrogen receptor beta 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 4-[4,4-difluoro-1-(2-fluorophenyl)cyclohexyl]phenol
INCHI InChI=1S/C18H17F3O/c19-16-4-2-1-3-15(16)17(9-11-18(20,21)12-10-17)13-5-7-14(22)8-6-13/h1-8,22H,9-12H2
InChi Key HSMUKSLNDJOZQG-UHFFFAOYSA-N
Canonical SMILES C1CC(CCC1(C2=CC=C(C=C2)O)C3=CC=CC=C3F)(F)F
Isomeric SMILES C1CC(CCC1(C2=CC=C(C=C2)O)C3=CC=CC=C3F)(F)F
PubChem CID 71245042
Molecular Weight 306.32

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 30.63, Max Conc. mM: 100; Soluble in methanol

Related Documents

References

1. McFarland K, Price DL, Davis CN, Ma JN, Bonhaus DW, Burstein ES, Olsson R.  (2013)  AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific neuroprotection in a Parkinson's disease rat model..  ACS Chem Neurosci,  (9): (1249-55).  [PMID:23898966]

Solution Calculators